Gene Ontology |
GO ID | Evidence Type | GO Description |
GO:0001798 |
IMP |
positive regulation of type IIa hypersensitivity |
GO:0001934 |
ISS |
positive regulation of protein phosphorylation |
GO:0001970 |
IMP |
positive regulation of activation of membrane attack complex |
GO:0004866 |
IEA |
endopeptidase inhibitor activity |
GO:0005515 |
IPI |
protein binding |
GO:0006631 |
IEA |
fatty acid metabolic process |
GO:0006954 |
IEA |
inflammatory response |
GO:0006956 |
IDA |
complement activation |
GO:0006957 |
IEA |
complement activation, alternative pathway |
GO:0006958 |
IEA |
complement activation, classical pathway |
GO:0010575 |
IEA |
positive regulation vascular endothelial growth factor production |
GO:0010828 |
ISS |
positive regulation of glucose transport |
GO:0010866 |
ISS |
regulation of triglyceride biosynthetic process |
GO:0010884 |
ISS |
positive regulation of lipid storage |
GO:0010951 |
IEA |
negative regulation of endopeptidase activity |
GO:0031715 |
ISS |
C5L2 anaphylatoxin chemotactic receptor binding |
GO:0045745 |
ISS |
positive regulation of G-protein coupled receptor protein signaling pathway |
GO:0045766 |
IMP |
positive regulation of angiogenesis |
GO:0050766 |
IMP |
positive regulation of phagocytosis |
GO:0070062 |
IEA |
extracellular vesicular exosome |
GO:0072562 |
IEA |
blood microparticle |
GO:2000427 |
IEA |
positive regulation of apoptotic cell clearance |